Got story updates? Submit your updates here. ›
Researchers are making significant strides in developing new cancer treatments that focus on empowering the body’s own immune system to fight cancer, rather than directly attacking tumors. This includes methods to reprogram immune cells within the body to recognize and attack cancer cells, as well as enhancing the broader immune response through therapies targeting the CD40 receptor. These advancements signal a shift towards more targeted, effective, and accessible cancer care.
Why it matters
Current cancer treatments like chemotherapy and radiation can be costly, have severe side effects, and are not always effective. The new immunotherapy approaches being developed offer the potential for more personalized, less invasive, and potentially more successful cancer treatments by harnessing the body’s natural defenses.
The details
Researchers at the University of California, San Francisco, have developed a method to reprogram immune cells within the body to target cancer cells, rather than the current approach of extracting cells, modifying them in a lab, and then re-infusing them. This internal reprogramming technique has shown promising results in studies on mice, including complete remission of some leukemia cases. Additionally, researchers are refining CD40-based therapies that stimulate the immune system’s broader response, with recent early-stage clinical trials showing tumor reduction in half of participants and complete remission in two cases.
Researchers at the University of California, San Francisco, have made this breakthrough in reprogramming immune cells within recent studies.A recent early-stage clinical trial involving 12 patients with metastatic cancer was conducted to test the CD40-based therapy.
The players
University of California, San Francisco
A leading research university that has made significant advancements in developing new cancer treatment approaches focused on harnessing the body’s immune system.
CD40 receptor
An immune cell receptor that can be stimulated to activate the broader immune system response against cancer.
Got photos? Submit your photos here. ›
What’s next
Researchers will continue to refine and test these new immunotherapy approaches in further clinical trials to evaluate their long-term safety and efficacy before potentially bringing them to market.
The takeaway
The promising results from these new immunotherapy techniques represent a significant shift in cancer treatment, moving away from the harsh side effects of traditional therapies and towards more personalized, targeted approaches that harness the power of the body’s own immune system to fight cancer.
